Results 61 to 70 of about 979 (187)
CNS Neuroscience &Therapeutics, Volume 32, Issue 2, February 2026.Optic neuropathy and glaucoma cause permanent visual deficits via retinal ganglion cell (RGC) loss and axon degeneration, affecting millions worldwide. Current treatments slow disease progression but cannot restore lost vision due to regeneration failure in adult RGCs.
Emma Beard +4 more
wiley +1 more source
BMC OphthalmologyBackground Preclinical technical feasibility study of robot-assisted microinvasive glaucoma surgery using a novel ophthalmic robot-assisted surgery system.
Gautam Kamthan +9 more
doaj +1 more source
Bio-Interventional Cyclodialysis and Allograft Scleral Reinforcement for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients: One-Year Clinical Outcomes. [PDF]
BACKGROUND: To evaluate the one-year safety and effectiveness of bio-interventional cyclodialysis and scleral reinforcement in open-angle glaucoma (OAG) patients undergoing cataract surgery.
Ahmed, Iqbal +7 more
core +2 more sources
Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with glaucoma [PDF]
, 2023 Background: Minimally invasive glaucoma procedures are emerging as clinically effective and safe glaucoma management approaches; however, evidence regarding quality-of-life outcomes is limited.
Jones, L +3 more
core
Microinvasive Glaucoma Surgery—A New Chapter in Glaucoma Management [PDF]
US Ophthalmic Review, 2016 The continuous search for techniques and devices that lower the intraocular pressure without the complications associated with our gold standard trabeculectomy procedure has led to some promising developments in glaucoma surgery. The newly emerging technologies place improved patient safety as a priority.
openaire +1 more source
Combined Microinvasive Glaucoma Surgery – A Review of the Literature and Future Directions
Seminars in Ophthalmology, 2023 The use of microinvasive invasive glaucoma surgery (MIGS) in the treatment of glaucoma has increased exponentially over the last 10 years. However, practice patterns vary widely given the relative newness of these technologies. Some surgeons perform two or more MIGS simultaneously, such as those that target aqueous production and those that target ...
Derek D, Mai +3 more
openaire +2 more sources
Animal Models and Experimental Medicine, Volume 7, Issue 3, Page 195-207, June 2024.Resveratrol (RES) exerts antioxidant and antiapoptotic effects on retinal ganglion cells (RGC) through various cellular and molecular mechanisms. First, RES has been found to protect RGCs from damage induced by oxidative stress and inflammation. It inhibits hypoxia‐induced RGC mortality by downregulating apoptosis and the production of ErbB2, a protein
Maryam Golmohammadi +10 more
wiley +1 more source
New Surgical Options in Glaucoma [PDF]
, 2015 The treatment of glaucoma is undergoing constant change. In the last decade, there has been a surge of novel surgical options that aim to lower intraocular pressure while providing improved safety profiles compared to traditional incisional glaucoma ...
Damji, Karim F +2 more
core +2 more sources
Secondary glaucoma: Toward interventions based on molecular underpinnings
WIREs Mechanisms of Disease, Volume 16, Issue 1, January/February 2024.Proposed effects of melatonin on anterior segment cells. Melatonin is a potent melanogenesis suppressor acting by inhibiting α‐MSH effects. As a result, melanin‐containing granules aggregate around the nucleus. Melatonin is a potent antioxidant capable of scavenging ROS/RNS generated by UV radiation (UV‐R).
Anna Mueller +4 more
wiley +1 more source
Development of a drug-eluting microstent for micro-invasive glaucoma surgery
Current Directions in Biomedical Engineering, 2018 Glaucoma represents the leading cause of irreversible blindness worldwide. Therapeutic approaches are based on the lowering of intraocular pressure (IOP).
Siewert Stefan +10 more
doaj +1 more source